Research Topics
| Mark W RussoSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis CMark W Russo
Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease and University of North Carolina at Chapel Hill, NC 27599 7080, USA
Liver Transpl 11:1235-41. 2005..004). In conclusion, hepatic stellate cell activation early after liver transplantation complements traditional testing for identifying liver transplant recipients with hepatitis C at greatest risk for developing advanced fibrosis...
Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis CMark W Russo
University of North Carolina, Division of Gastroenterology and Hepatology, Bioinformatics Bldg Rm 1104, 130 Mason Farm Road, Chapel Hill, NC 27599 7080, USA
Nephrol Dial Transplant 21:437-43. 2006..Chronic hepatitis C infection is prevalent among haemodialysis patients. The goal of our study was to determine the efficacy and safety of pegylated interferon alpha-2b in haemodialysis patients with chronic hepatitis C...
Liver transplantation for acute liver failure from drug induced liver injury in the United StatesMark W Russo
Division of Gastroenterology and Hepatology, Department of Medicine and Center for Gastrointestinal Biology and Diseases, University of North Carolina, Chapel Hill, NC 27599 7080, USA
Liver Transpl 10:1018-23. 2004..The increased frequency of African-American women undergoing liver transplantation for non-APAP drug induced liver injury warrants further study...
Interpretation of liver chemistries in adult donors after living donor liver transplantationMark W Russo
Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, New York, USA
J Clin Gastroenterol 38:810-4. 2004..The safety of donors is paramount in adult living donor liver transplantation. Our goal is to compare the pattern of recovery of hepatic synthetic function and aminotransferases in healthy adult donors with and without complications...
Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis CMark W Russo
Department of Medicine and the Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA
Am J Transplant 4:1133-8. 2004..Older donor age is associated with lower short-term graft survival in recipients with hepatitis C, but not in recipients with cholestatic or alcoholic liver disease...
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United StatesMark W Russo
Department of Medicine, University of North Carolina, Chapel Hill, NC 27599 7080, USA
Liver Transpl 10:340-6. 2004..68. Short-term patient and graft survival are similar between living donor and deceased donor liver transplant recipients with hepatitis C suggesting that recurrent hepatitis C does not seem to affect short-term outcomes...
Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantationMark W Russo
Division of Digestive Diseases, University of North Carolina, Chapel Hill, NC, USA
Am J Transplant 4:427-31. 2004..In the era of living donor liver transplantation, estimates of patient survival should incorporate waiting time mortality...
How to use statins in patients with chronic liver diseaseMark W Russo
Center for the Study of Hepatitis C, Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY, USA
Cleve Clin J Med 71:58-62. 2004..However, patients with acute liver disease (acute viral hepatitis, alcoholic hepatitis) should not take statins until they have recovered...
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donorsPaul J Gaglio
Department of Medicine, Columbia University College of Physicians and Surgeons, Center for Liver Disease and Transplantation, New York Presbyterian Hospital, New York, NY 10032, USA
Liver Transpl 9:1028-35. 2003..Thus, in this patient population, the timing and incidence of HCV recurrence were not different when comparing CAD versus LDLT, but the incidence of cholestatic hepatitis was significantly greater in patients with HCV who underwent LDLT...
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson
Department of Gastroenterology and Hepatology, Weill Medical School of Cornell University, 450 East 69th Street, New York, NY 10021, USA
Am J Gastroenterol 99:1700-5. 2004..Patients with CHC should not be excluded from treatment on the basis of ALT alone. Combination therapy with pegylated interferon and ribavirin should be evaluated in these patients...
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis CIra M Jacobson
Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, New York 10021, USA
Am J Gastroenterol 100:2453-62. 2005..There was no significant effect of dosing regimen...
Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteriaTarun K Narang
Department of Medicine, Carolinas Medical Center, Charlotte, NC 28203, USA
Liver Transpl 16:1228-35. 2010..We propose that studies on PLTCHC use the consensus criteria for diagnosis and suggest clinical information that should be provided in future studies with the goal of improving our understanding and management of this deadly disease...
Management of newly diagnosed hepatitis C virus infectionMark W Russo
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, USA
Cleve Clin J Med 70:S14-20. 2003..Careful and timely management of side effects, which are experienced by all patients, can improve adherence to antiviral therapy and further improve response rates...
The burden of gastrointestinal and liver diseases, 2006Nicholas J Shaheen
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Am J Gastroenterol 101:2128-38. 2006..CONCLUSIONS: Gastrointestinal and liver diseases are significant contributors to the morbidity, mortality, and health-care expenditures of the U.S. population...
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discoveryYong Yook Lee
Department of Research, Carolinas HealthCare System, Charlotte, NC, USA
J Proteome Res 10:5070-83. 2011..Here we demonstrate an efficient strategy of subcellular tissue proteomics toward molecular target discovery of one of the most complicated human disease, HCC...
Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortalityMark W Russo
Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7080, USA
Am J Gastroenterol 98:2521-7. 2003..Renal insufficiency, refractory encephalopathy, and hyperbilirubinemia were consistently associated with mortality after TIPS. In individuals with risk factors for mortality, alternative strategies should be recommended...
Guidelines for stopping therapy in chronic hepatitis CMark W Russo
Division of Gastroenterology and Hepatology, University of North Carolina, CB#7080, Room 1111, Bioinformatics Building, Mason Farm Road, Chapel Hill, NC 27599, USA
Curr Gastroenterol Rep 6:17-21. 2004..Progress in defining early treatment stopping points has reduced adverse events in patients who are unlikely to respond to therapy...
Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosisK Shiva Kumar
Center for Liver Disease and Transplantation, New York-Presbyterian Hospital, New York 10036, USA
Gastroenterology 122:2026-31. 2002..This is the first reported patient with primary amyloidosis to undergo sequential liver and stem cell transplantation leading to resolution of the disease and only the second to undergo successful liver transplantation for this disorder...
Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patientsRobert S Brown
Center for Liver Disease and Transplantation, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA
Liver Transpl 8:278-84. 2002..However, neither score correlated with resource use post-OLT in the strata of critically ill patients...
Side effects of therapy for chronic hepatitis CMark W Russo
Division of Digestive Diseases, University of North Carolina at Chapel Hill, 27599, USA
Gastroenterology 124:1711-9. 2003
Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safetyMark W Russo
Division of Digestive Diseases and Nutrition, University of North Carolina, Chapel Hill, North Carolina 27599, USA
Am J Gastroenterol 98:1610-5. 2003..Interferon monotherapy is associated with more adverse events in dialysis patients. The optimal dose and duration of interferon monotherapy and selection criteria of dialysis patients need to be studied further in clinical trials...
Adult living donor liver transplantationMark W Russo
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
Am J Transplant 4:458-65. 2004..Further growth of LDLT will depend on defining the optimal recipient and donor characteristics for this procedure as well as broader acceptance and experience in the public and in transplant centers...
A survey of liver transplantation from living adult donors in the United StatesRobert S Brown
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
N Engl J Med 348:818-25. 2003..Although the use of grafts from living donors is standard practice in transplantation in children, their use in adults remains controversial...
Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donorsDianne Lapointe Rudow
Center for Liver Disease and Transplantation, New York Presbyterian Hospital, New York, NY, USA
Liver Transpl 9:254-9. 2003..Further understanding of the cultural differences and motivating factors for why people volunteer for evaluation and subsequently choose to donate may help improve cadaveric and living donor transplant rates...
Drug-induced liver injury associated with statinsMark W Russo
Department of Medicine, Carolinas Medical Center, Charlotte, North Carolina 28203, USA
Semin Liver Dis 29:412-22. 2009..Multiple retrospective studies as well as a large prospective randomized controlled trial demonstrate that statins can safely be given to hyperlipidemic patients with compensated chronic liver disease...
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRITilak U Shah
Division of Gastroenterology and Hepatology and Center for Gastroenterology Biology and Disease, University of North Carolina, Chapel Hill, NC 27599-7080, USA
Am J Gastroenterol 101:533-40. 2006..CONCLUSION: The incidence of HCC in patients with small liver nodules is significantly higher compared to patients with cirrhosis without liver nodules. The presence of small liver nodules warrants increased imaging surveillance for HCC...
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis CK Shiva Kumar
Center for Liver Disease and Transplantation, New York-Presbyterian Hospital, New York, USA
Am J Gastroenterol 97:2432-40. 2002..Though usually reversible, at least one case has required long-term steroids with inadequate resolution. Though pulmonary toxicity is rare, symptoms which are more than mild or progressive in nature should likely be investigated...
Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidatesTilak U Shah
Department of Gastroenterology and Hepatology and Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA
Liver Transpl 12:1682-8. 2006..In conclusion, in our study group MRI detected PVT in all liver transplant recipients requiring jump grafts at transplantation. The major reason for a false-positive MRI was a diminutive but patent portal vein...
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trialNicholas J Shaheen
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
Hepatology 41:588-94. 2005..However, the total ulcer number and patient symptoms were not different between the groups...
Financial impact of adult living donationMark W Russo
University of North Carolina, Chapel Hill, NC, USA
Liver Transpl 9:S12-5. 2003
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humansAlison H Harrill
Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
Genome Res 19:1507-15. 2009..These studies demonstrate that a diverse mouse population can be used to understand and predict adverse toxicity in heterogeneous human populations through guided resequencing...
Ethical issues in living donor liver transplantationMark W Russo
Center for Liver Disease and Transplantation, Columbia Presbyterian Medical Center, 622 West 168th Street, PH 14, New York, NY 10032, USA
Curr Gastroenterol Rep 5:26-30. 2003..The medical community has an obligation to study carefully the risks and outcomes associated with ALDT so that we can deliver the highest quality of care that is not at the expense of healthy individuals...
Digestive and liver diseases statistics, 2004Mark W Russo
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599-7555, USA
Gastroenterology 126:1448-53. 2004..Following trends in utilization is important for determining allocation of resources for health care and research...
Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver diseaseJason D Conway
Department of Medicine: Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, 27599-7080, USA
Gastrointest Endosc 61:32-6. 2005..CONCLUSIONS: Endoscopic stent placement in the gallbladder is a safe and an effective palliative treatment for patients with symptoms caused by gallbladder disease who are poor surgical candidates...
Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shuntMark W Russo
Weill Medical College of Cornell University, New York, NY, USA
Liver Transpl 8:271-7. 2002..Individuals with both coagulopathy and renal insufficiency had high mortality. Urgent TIPS placement for uncontrolled variceal bleeding was associated with stenosis...
Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literatureEvan S Dellon
University of North Carolina School of Medicine, Division of Gastroenterology and Hepatology, CB 7080, Bioinformatics Bldg, Rm 1140, 130 Mason Farm Rd, Chapel Hill, NC 27599 7080, United States
World J Gastroenterol 12:4089-92. 2006..This case demonstrates that liver biopsy is essential in diagnosing unusual causes of acute liver failure, and that infiltration of the liver with NK-like T-cell lymphoma/leukemia can cause acute liver failure...
Liver function tests and statinsPhilippe J Zamor
Department of Medicine, Center for Liver Diseases and Transplantation, Carolinas Medical Center, Charlotte, North Carolina 28203, USA
Curr Opin Cardiol 26:338-41. 2011..To discuss recent data on statins in patients with elevated liver tests...
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosisPradyumna Phatak
Rochester General Hospital, Rochester, NY, USA
Hepatology 52:1671-779. 2010..Based on the safety and efficacy results, starting deferasirox at 10 mg/kg/day appears to be most appropriate for further study in this patient population...
Discovery of putative pancreatic cancer biomarkers using subcellular proteomicsKimberly Q McKinney
Proteomics Laboratory for Clinical and Translational Research, Carolinas HealthCare System, Charlotte, NC, USA
J Proteomics 74:79-88. 2011..We conclude that subcellular fractionation followed by gel electrophoresis and tandem mass spectrometry is a powerful strategy for identification of differentially expressed proteins in pancreatic cancer...
Reporting outcomes on living donor liver transplantMark W Russo
Liver Transpl 11:244; author reply 245. 2005
Is severe recurrent hepatitis C more common after adult living donor liver transplantation?Mark W Russo
Hepatology 40:524-6. 2004
Are patients with elevated liver tests at increased risk of drug-induced liver injury?Mark W Russo
Gastroenterology 126:1477-80. 2004
Evaluating the potential living liver donorMark W Russo
Liver Transpl 10:1097-8. 2004
MELD and serum sodiumMark W Russo
Hepatology 41:1198-9; author reply 1199; discussion 1199. 2005
A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesiaSamia N Khalil
Department of Anesthesiology, University of Texas Health Science Center, Houston 77030, USA
Anesth Analg 101:356-61, table of contents. 2005..1 mg/kg) in the prevention of postoperative emesis in 1- to 24-mo-old pediatric patients undergoing elective surgery under general anesthesia...
